Delivery Order SPE2DB24D1205-SPE2DB25FCXFN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Qnasl 80 mcg nasal spray (10.6 grams) with a ceiling value of $4,980.26. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,542.48 to AmerisourceBergen Drug Corp for QNASL 80 MCG Nasal Spray (10.6 GM) with a completion deadline of September 23, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, supporting the agency's medical supply chain operations. This delivery order...
- This delivery order, awarded September 5, 2025, provides QNASL 80 MCG nasal spray (10.6 GM) to the Defense Logistics Agency (DLA) through AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract represents a firm fixed-price delivery order with a ceiling value of $4,189.84 and an ultimate completion date of September 8, 2025. The award was competitively awarded with no set-aside designation,...
- This is a $1,322.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of QNASL 80 MCG nasal spray. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,204.30 to AmerisourceBergen Drug Corp for Qnasal 80 mcg nasal spray (10.6 grams) on September 10, 2025, with an ultimate completion date of September 11, 2025. This contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters, where AmerisourceBergen maintains its corporate operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,003.97 to AmerisourceBergen Drug Corp for Qnasal 80 micrograms nasal spray (10.6 grams) on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitive award, which carries no set-aside designation, is categorized as a firm fixed-price delivery order. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply QNASL 80 MCG NASAL SPRAY 10.6GM. This $4,163.41 award is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that allows AmerisourceBergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has no set-aside...
- The Defense Logistics Agency awarded a $359,560 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561880875 nasal spray. The prime contractor will provide 10.6 grams of QNASL 80 microgram nasal spray to fulfill requirements under the contract. Performance will take place in Conshohocken, Pennsylvania from August 21-22, 2023. The Defense Logistics Agency facilitates worldwide logistics support for the United States Department of Defense and partners, and this delivery...
- This $1,717.61 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) on June 12, 2024. The order is for the supply of 4564885519 QNASL 80 MCG Nasal Spray 10.6GM, a pharmaceutical product, with a completion date of June 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This is a $1,899.72 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM, a pharmaceutical product, with a performance period through April 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXFNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for Qnasl 80 mcg nasal spray (10.6 grams) with a contract ceiling value of $2,486.72 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of June 2, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company holds an extensive portfolio of delivery orders with the Defense Logistics Agency covering a wide spectrum of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for nasal spray medication represents one of numerous competitively awarded transactions demonstrating AmerisourceBergen's capability to fulfill diverse federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 5/30/25 |